Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Unknown × osimertinib × Clear all

Phase

Phase 2 15 Phase 1 4 Phase NA 2 Phase 3 2 Phase 1/2 2 Phase 4 1

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Metformin 12 Drug Therapy 11 Cyclophosphamide 11 Dexamethasone 10 Cytarabine 10 Cisplatin 10 Carboplatin 8 icotinib 7 Sodium Chloride 7 Radiotherapy 7 Oxaliplatin 7 Docetaxel 7 ulipristal acetate 6 Vincristine 6 Paclitaxel 6 Gemcitabine 6 Fluorouracil 6 Dexmedetomidine 6 entecavir 5 Thalidomide 5 Surgical Procedures, Operative 5 S 1 (combination) 5 Propranolol 5 Pemetrexed 5 Methotrexate 5 Leuprolide 5 Idarubicin 5 Granulocyte Colony-Stimulating Factor 5 Endostatins 5 Doxorubicin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05785208 2023-03-27

TEMPLE-2

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡